HBI Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Harvard Bioscience Inc

Watchlist Manager

Watchlist

Price: 4.26 EUR Market Closed

Market Cap: €274.9m

H	Harvard Bioscience Inc SWB:HBI	US
S	Sekisui Chemical Co Ltd OTC:SKSUY	JP
P	Pensionbee Group PLC F:6HD	UK
F	Fennec Pharmaceuticals Inc TSX:FRX	US
L	LHC Group Inc F:LH6	US
S	Scor SE SWB:SDRC	FR
A	Austal Ltd F:LX6	AU

Profitability Summary

Harvard Bioscience Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Strong 3Y Average Gross Margin

58%

Gross Margin is Increasing

55% > 58%

Negative Operating Margin

-1%

Negative 3Y Average Operating Margin

-3%

Operating Margin is Increasing

-3% > -1%

Negative Net Margin

-66%

Negative 3Y Average Net Margin

-28%

Declining Net Margin

-2% > -66%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

3% > 6%

Negative ROE

-147%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2%

ROIC is Increasing

-6% > 0%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.